AstraZeneca in Talks to Merge With Bristol Myers Squibb in Potential $400B Pharma Megadeal — BigGo Finance
UK drugmaker AstraZeneca has held exploratory talks with US rival Bristol Myers Squibb about a potential merger that…
AstraZeneca maintains outlook as cancer, rare disease drugs drive profit beat
July 27 (Reuters) – AstraZeneca backed its annual and long-term forecasts on Monday after topping second-quarter profit expectations…
Astrazeneca Q2 Earnings Call Highlights
Key Points Interested in Astrazeneca Plc? Here are five stocks we like better. Solid first-half performance: AstraZeneca reported…
AstraZeneca profit rises on strong cancer drug sales
AstraZeneca reconfirmed its outlook for the full year (Hector RETAMAL) British pharmaceutical giant AstraZeneca on Monday said net…
AstraZeneca profit rises on strong cancer drug sales
AstraZeneca reconfirmed its outlook for the full year (Hector RETAMAL) British pharmaceutical giant AstraZeneca on Monday said net…
AstraZeneca says AI is raising its odds where most drugs fail
The most expensive product in modern business is the one that never ships. Nowhere is that more true…
AstraZeneca says AI is raising its odds where most drugs fail
The most expensive product in modern business is the one that never ships. Nowhere is that more true…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
What next for AstraZeneca shares, after another cracking quarter?
Image source: Getty Images AstraZeneca (LSE: AZN) shares wobbled a bit Wednesday morning (29 April), even though the…
AstraZeneca to inject £300 million into UK in surprise U-turn
Pharmaceutical giant AstraZeneca is set to inject £300 million into UK drug development after halting a £200 million…